Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond
P Libby - Journal of the American College of Cardiology, 2017 - jacc.org
Inflammatory pathways drive atherogenesis and link conventional risk factors to
atherosclerosis and its complications. One inflammatory mediator has come to the fore as a …
atherosclerosis and its complications. One inflammatory mediator has come to the fore as a …
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.
P Libby - Journal of the American College of Cardiology, 2017 - europepmc.org
Inflammatory pathways drive atherogenesis and link traditional risk factors to atherosclerosis
and its complications. One inflammatory mediator has come to the fore as a therapeutic …
and its complications. One inflammatory mediator has come to the fore as a therapeutic …
[HTML][HTML] Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond
P Libby - Journal of the American College of Cardiology, 2017 - Elsevier
Inflammatory pathways drive atherogenesis and link conventional risk factors to
atherosclerosis and its complications. One inflammatory mediator has come to the fore as a …
atherosclerosis and its complications. One inflammatory mediator has come to the fore as a …
[引用][C] Interleukin-1 Beta as a Target for Atherosclerosis Therapy
P Libby - Journal of the American College of Cardiology, 2017 - cir.nii.ac.jp
Interleukin-1 Beta as a Target for Atherosclerosis Therapy | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[HTML][HTML] Interleukin-1 Beta as a Target for Atherosclerosis Therapy: The Biological Basis of CANTOS and Beyond
P Libby - Journal of the American College of Cardiology, 2017 - ncbi.nlm.nih.gov
Inflammatory pathways drive atherogenesis and link traditional risk factors to atherosclerosis
and its complications. One inflammatory mediator has come to the fore as a therapeutic …
and its complications. One inflammatory mediator has come to the fore as a therapeutic …
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond
P Libby - Journal of the American College of Cardiology, 2017 - pubmed.ncbi.nlm.nih.gov
Inflammatory pathways drive atherogenesis and link conventional risk factors to
atherosclerosis and its complications. One inflammatory mediator has come to the fore as a …
atherosclerosis and its complications. One inflammatory mediator has come to the fore as a …